Alcoa to Consider Next Steps for the San Ciprián Smelter in Spain

Alcoa to Consider Next Steps for the San Ciprián Smelter in Spain

PITTSBURGH–(BUSINESS WIRE)–
Alcoa Corporation announced today that it will halt curtailment plans for its San Ciprián aluminum smelter in Spain while it reviews a court decision related to a collective dismissal process.

On October 9, 2020, Alcoa announced its decision to curtail the smelter’s 228,000 metric tons of annual capacity and proceed with the collective dismissal of employees after completing four months of consultations with the workers’ representatives at the San Ciprián aluminum plant. The alumina refinery at San Ciprián was not included in the consultation.

The workers’ representatives filed a lawsuit with the High Court of Justice of Galicia, which ruled in favor of the workers on Thursday, December 17, 2020. In the court’s ruling, it declared the collective dismissal process “null and void.”

As a result, in the fourth quarter of 2020, the Company will not incur the approximately $35 million to $40 million it previously announced as an expected charge for employee-related costs associated with the curtailment and collective dismissal process.

In addition, due to a related labor strike at both the San Ciprián aluminum smelter and alumina refinery, the Company will record a negative impact on income before income taxes in the fourth quarter 2020 of approximately $10 million, primarily related to the refinery. The court’s ruling does not resolve the labor strike.

The Company believes it has acted in good faith and in full compliance with the law. The need to restructure the San Ciprián smelter persists due to significant and permanent structural issues.

About Alcoa

Alcoa (NYSE: AA) is a global industry leader in bauxite, alumina, and aluminum products, and is built on a foundation of strong values and operating excellence dating back more than 130 years to the world-changing discovery that made aluminum an affordable and vital part of modern life. Since developing the aluminum industry, and throughout our history, our talented Alcoans have followed on with breakthrough innovations and best practices that have led to efficiency, safety, sustainability, and stronger communities wherever we operate. Visit us online on www.alcoa.com, follow @Alcoa on Twitter, and on Facebook at www.facebook.com/Alcoa.

Forward-Looking Statements

This news release contains statements that relate to future events and expectations and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those containing such words as “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “outlook,” “plans,” “projects,” “seeks,” “sees,” “should,” “targets,” “will,” “would,” or other words of similar meaning. All statements by Alcoa Corporation that reflect expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and changes in circumstances that are difficult to predict. Although Alcoa Corporation believes that the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that these expectations will be attained and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks and uncertainties. Additional information concerning factors that could cause actual results to differ materially from those projected in the forward-looking statements is contained in Alcoa Corporation’s filings with the Securities and Exchange Commission. Alcoa Corporation disclaims any obligation to update publicly any forward-looking statements, whether in response to new information, future events or otherwise, except as required by applicable law.

Dissemination of Company Information

Alcoa Corporation intends to make future announcements regarding company developments and financial performance through its website, www.alcoa.com, as well as through press releases, filings with the Securities and Exchange Commission, conference calls and webcasts.

Investor Contact

James Dwyer

412-992-5450

[email protected]

Media Contacts

Jim Beck

412-315-2909

[email protected]

Clara Acebes

Spain

+34 914068280

[email protected]

KEYWORDS: Pennsylvania New York Europe Spain United States North America

INDUSTRY KEYWORDS: Engineering Mining/Minerals Manufacturing Natural Resources Other Manufacturing Steel

MEDIA:

Logo
Logo

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

WOODSTOCK, Ga.–(BUSINESS WIRE)–
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn® Technology products into the dental market and has accepted its first order.

Endocyn®, a Microcyn® Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endodontics, Endocyn demonstrated less cellular toxicity compared to traditional endodontic irrigants such as sodium hypochlorite. The full study can be found here: http://www.sciencedirect.com/science/article/abs/pii/S0099239917310439

“We believe Endocyn and the Microcyn family of hypochlorous acid products are the next generation of products to help in the management of a myriad of dental, head and neck conditions” said Dr. Mark Fontenot, managing member at Gabriel Science, LLC. “The Microcyn family of HOCl products is a much needed addition to the treatment options available to dental healthcare providers given Microcyn’s superior performance.”

“We are pleased to bring this cutting-edge advance in dental products to the U.S. market and to partner with Gabriel Science,” said Amy Trombly, CEO of Sonoma Pharmaceuticals. “Our proprietary Microcyn technology is truly the next-generation formulation in terms of superior antimicrobial impact, shelf stability and safety. This partnership also furthers Sonoma’s strategy of expanding its offerings of Microcyn-powered products available in the U.S. market.”

About Gabriel Science, LLC

Gabriel Science, LLC is a life science company dedicated to providing advanced therapies and products for the professional management of oral, dental, maxillofacial, and head and neck conditions. In collaboration with leading clinicians, Gabriel Science distributes and sells proprietary products for tissue regeneration, wound healing, and head and neck disease management. Gabriel Science is a U.S.-based company located in Niwot, Colorado ([email protected]).

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 53 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com. For partnership opportunities, please contact [email protected].

Forward-Looking Statements

Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the “company”). These forward-looking statements are identified by the use of words such as “continue,” “develop” and “expand,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company’s business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company’s products will not be as large as expected, the company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company’s cash needs, fund further development, as well as uncertainties relative to the COVID-19 pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law.

Sonoma Pharmaceuticals™, Microcyn® and Endocyn® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

Media and Investor Contact:

Sonoma Pharmaceuticals, Inc.

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Health Dental Research Pharmaceutical Science Biotechnology

MEDIA:

Logo
Logo

Bank of America Announces Full Redemption of Depositary Shares Representing Interests in Its 6.200% Non-Cumulative Preferred Stock, Series CC

Bank of America Announces Full Redemption of Depositary Shares Representing Interests in Its 6.200% Non-Cumulative Preferred Stock, Series CC

CHARLOTTE, N.C.–(BUSINESS WIRE)–
Bank of America Corporation announced today that it will redeem all outstanding shares of its 6.200% Non-Cumulative Preferred Stock, Series CC (the “Series CC Preferred Stock”), and the corresponding depositary shares representing fractional interests in the Series CC Preferred Stock (the “Series CC Depositary Shares”), on January 29, 2021.

All 44,000,000 Series CC Depositary Shares (NYSE: BAC PrC) (CUSIP No. 060505286), each representing a 1/1,000th interest in one share of the Series CC Preferred Stock, will be redeemed on the dividend payment date on January 29, 2021, simultaneously with the redemption of the Series CC Preferred Stock, at a redemption price of $25 per depositary share. Declared dividends of $0.3875 per depositary share on the outstanding Series CC Depositary Shares for the full current quarterly dividend period will be paid separately on January 29, 2021 to holders of record on January 1, 2021, in the customary manner. Accordingly, the redemption price of $25 per depositary share does not include any accrued and unpaid dividends, and dividends on the redeemed depositary shares will cease to accrue on the redemption date.

The Series CC Depositary Shares are held through The Depository Trust Company (DTC) and will be redeemed in accordance with the procedures of DTC. Payment to DTC for the Series CC Depositary Shares will be made by Computershare Inc. and Computershare Trust Company, N.A., collectively, as redemption agent, in accordance with the Deposit Agreement governing the Series CC Depositary Shares. The address for the redemption agent is as follows:

Computershare Trust Company, N.A.

Attn: Corporate Actions

150 Royall St.

Canton, MA 02021

Bank of America has received all necessary approvals for this redemption.

Bank of America

Bank of America is one of the world’s leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 66 million consumer and small business clients with approximately 4,300 retail financial centers, including approximately 2,900 lending centers, 2,500 financial centers with a Consumer Investment Financial Solutions Advisor and 2,300 business centers; approximately 17,000 ATMs; and award-winning digital banking with approximately 39 million active users, including approximately 31 million mobile users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 3 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and approximately 35 countries. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange.

Forward-looking statements

Certain information contained in this news release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future results or performance and involve certain risks, uncertainties and assumptions difficult to predict or beyond our control. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed in our 2019 Annual Report on Form 10-K, our quarterly reports on Form 10-Q for the periods ended March 31, 2020, June 30, 2020 and September 30, 2020 and subsequent Securities and Exchange Commission filings. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update any forward-looking statement to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made.

For more Bank of America news, including dividend announcements and other important information, visit the Bank of America newsroom and register for news email alerts.

www.bankofamerica.com

Investors May Contact:

Lee McEntire, Bank of America

Phone: 1.980.388.6780

[email protected]

Jonathan Blum, Bank of America (Fixed Income)

Phone: 1.212.449.3112

[email protected]

Reporters May Contact:

Jerry Dubrowski, Bank of America

Phone: 1.646.855.1195 (office) or 1.508.843.5626 (mobile)

[email protected]

Christopher P. Feeney, Bank of America

Phone: 1.980.386.6794

[email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Tredegar Corporation Announces Retirement of Michael J. Schewel; Kevin C. Donnelly Appointed as Vice President, General Counsel and Corporate Secretary

Tredegar Corporation Announces Retirement of Michael J. Schewel; Kevin C. Donnelly Appointed as Vice President, General Counsel and Corporate Secretary

RICHMOND, Va.–(BUSINESS WIRE)–
Tredegar Corporation (NYSE:TG) today announced the retirement of Michael J. Schewel as Executive Vice President, General Counsel and Corporate Secretary, and the appointment of Kevin C. Donnelly to the position of Vice President, General Counsel and Corporate Secretary, effective January 1, 2021.

Mr. Schewel has served at Tredegar Corporation since 2016. Mr. Donnelly joined Tredegar in 2010 and has served as its Associate General Counsel since 2013. Prior to joining Tredegar, Mr. Donnelly was an associate at Hunton & Williams LLP (now Hunton Andrews Kurth LLP). He received a B.A. degree from the University of Richmond and a J.D. from the University of Virginia.

John M. Steitz, President and CEO of Tredegar, commented, “Mike Schewel has been an invaluable member of our management team. He will certainly be missed. We are fortunate to have Kevin Donnelly as Mike’s highly qualified successor. Kevin knows Tredegar and its businesses and has served ably as our Associate General Counsel for the past seven years.”

Tredegar Corporation is an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building and construction, automotive and specialty markets; surface protection films for high technology applications in the global electronics industry; and specialized polyester films primarily for the Latin American flexible packaging market. Tredegar had 2019 sales from continuing operations of $826 million. With approximately 2,500 employees, the Company operates manufacturing facilities in North America, South America and Asia.

Neill Bellamy

Phone: 804/330-1211

E-mail: [email protected]

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Packaging Chemicals/Plastics Other Manufacturing Manufacturing

MEDIA:

Logo
Logo

First Responders Children’s Foundation First Annual Toy Express Delivers Over $200,000 Worth of Toys to the Greenbrier Resort for Dream Tree for Kids

NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — First Responders Children’s Foundation, a nonprofit organization that supports children of first responders and their families, delivered over $200,000 worth of holiday toys to The Greenbrier resort in White Sulphur Springs, West Virginia to be distributed as part of their annual Dream Tree for Kids event. The Foundation, which is a longtime partner of Greenbrier, used its Toy Express to support the resort’s continuing efforts to serve needy children in the community. Dream Tree for Kids was started in 2011 by the Justice family, which owns the resort, as a means to give toys to children across the state and region who would otherwise go without for the holidays. Each year $1 million worth of toys are distributed, and this year the First Responders Children’s Foundation was proud to be a significant contributor.

“Thank you to the Justice family for their yearlong efforts in supporting their community, said Jillian Crane, President of First Responders Children’s Foundation. “We’re proud to continue to support The Greenbrier’s work with helping local children, and we look forward to being a part of the Dream Tree for years to come.”

First Responders Children’s Foundation established the Toy Express with a generous toy donation worth more than $3,500,000 in retail value from Mattel and American Girl including 5,000 signature 18” American Girl dolls and more than 45,000 in other Mattel products such as Hot Wheels®, Barbie® and Mega Bloks®. Additional sponsors include CSX, Good360, Hess Toy Truck, Jakks Pacific, MaskUSA.com, and Toys for Tots. In addition, generous individuals across the nation are helping bring holiday cheer to first responder families by making donations of toys and money. Transportation of toys and masks across the country is coordinated and provided by Total Quality Logistics (TQL) and their Moves that Matter program.

By the end of the holiday season, First Responders Children’s Foundation’s Toy Express will have delivered almost 250,000 free toys and masks through various COVID-safe events throughout the country.

An Electronic Press Kit can be accessed here.

First Responders Children’s Foundation began in the wake of 9/11 when Founder and Chairman, Alfred R. Kahn, hosted the first annual Thanksgiving Day Parade Breakfast just weeks after the 9/11 attacks. That year, more than 800 children and family members of first responders lost in the line of duty were invited to watch the Thanksgiving Day Parade from private, front-row viewing which began an annual tradition of welcoming devastated first responder families into a supportive environment to face the challenges of the start of a holiday season without a loved one. 19 years later, the Foundation continues to support the families of first responders across the country with critical assistance including college scholarships and financial grants including paying for funeral bills of first responders who made the ultimate sacrifice in service to their community. During the 2020 pandemic, the Foundation has assisted more than 677,638 first responders through its COVID-19 Emergency Response Fund. This holiday season, First Responders Children’s Foundation’s Toy Express will help provide cheer and happiness to children and families of first responders. Media assets for Toy Express can be found at https://1strcf.org/toy-express/.

Media Contact:
Joanna Black
+1 (646) 912-2681
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/374a74db-250f-4537-bddf-13efbd013f80



Xebec Expands Product Portfolio and Enters German Hydrogen and Renewable Natural Gas Markets with Acquisition of Inmatec


– Acquisition fills product gaps in onsite Oxygen and Nitrogen generators for industrial and medical applications, and provides German sales and service network –

ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE STATED

Key Transaction Highlights

  • Expanding industrial gas product portfolio and Cleantech Service Network with the acquisition of Inmatec, a German-based manufacturer of best-in-class onsite nitrogen and oxygen generators
  • Acquiring leading oxygen and nitrogen generation technology with a reference base of over 8,000 installed systems worldwide
  • Increasing Cleantech Service Network coverage with parts of Europe, the Middle East and Africa through Inmatec’s existing service capabilities
  • Entering the German hydrogen and renewable natural gas (RNG) markets, by leveraging Inmatec’s local sales and service teams to reach the country’s evolving hydrogen opportunities and 8,900 active biogas installations
  • Leveraging the existing distribution network consisting of 40+ partners worldwide for cross-selling opportunities
  • Exposure to the fast-growing medical oxygen market with turnkey hospital oxygen generators and systems

MONTREAL, Dec. 17, 2020 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (“Xebec” or the “Corporation”), a global provider of clean energy solutions, is pleased to announce it has entered into a definitive agreement to acquire all of the issued and outstanding shares of Inmatec Gase Technologie GmbH & Co. KG, Inmatec GmbH and Inmatec Gas Technology FZC RAK (collectively, “Inmatec”), in the United Arab Emirates (the “Acquisition”).

“We’re excited to be announcing another strategic acquisition for us this month. Inmatec builds on our thesis for onsite generation of gases as it enables customers to achieve significant cost and emission reductions,” said Kurt Sorschak, Chairman, CEO and President of Xebec Adsorption Inc. “Inmatec is one of the world leaders in onsite nitrogen and oxygen generators and has achieved impressive scale with over 8,000 units deployed worldwide. Their German manufacturing and engineering capabilities have resulted in a reputation for high quality and extremely reliable products.”

“Notably, Inmatec complements both our onsite hydrogen generators, which are produced by HyGear and our own industrial air and renewable natural gas products. We see good value in cross-selling these solutions throughout our industrial service companies in North America and our combined customer base. Most importantly, Inmatec will give us a Cleantech Service Network footprint in parts of Europe, the Middle East and Africa, and an entry into the German hydrogen and RNG market. There are over 8,900 biogas installations which could be converted to produce RNG and Germany has announced plans to invest up to Euro 9 billion in hydrogen. Inmatec is ideally positioned to leverage their 40+ distribution partners to also sell our renewable natural gas and hydrogen systems.”

“As we look forward to 2021, we’re excited to be increasing the scope of our capabilities and evolve into a truly global company. I’d like to once again congratulate all the teams on all their hard work and give Inmatec a warm welcome to the Xebec family,” added Mr. Sorschak.

Inmatec Acquisition Overview and Rationale

Worldwide leader in onsite nitrogen and oxygen products
Founded in 1993, Inmatec is an international market leader in the production of nitrogen and oxygen generators. Designed, developed and produced in Germany, over 8,000 Inmatec systems have been deployed and sold around the world. Similar to HyGear, onsite generation of nitrogen and oxygen reduces the need for transportation, saving on costs and reducing the burden on the environment.

Growth opportunities by bringing products to North America and cross-selling

Inmatec’s products and manufacturing are among the best-in-class and this acquisition will give Xebec an accelerated entry into offering these products in North America. Currently, Inmatec’s target markets are in parts of Europe, the Middle East and Africa (“EMEA”). Due to the complementary nature of customers and industries, Xebec’s and HyGear’s products can also be sold through Inmatec, giving another sales channel and platform for growth in the EMEA region.

Cleantech Service Network expansion into Europe and entry into German Hydrogen renewable natural gas markets

With over 260 technicians actively servicing equipment across Europe, Inmatec’s own and partner workforce will be retrained and retooled to work with renewable gases. This positions Xebec favorably in the purchasing decision process when customers select a vendor for a multi-million-dollar hydrogen or renewable natural gas installation. Xebec believes service is an important customer need and sees it as a competitive advantage due to the lack of a similar offerings from other vendors.

In addition, Inmatec’s distribution network of 40+ worldwide and regional partners create an opportunity to enter Germany’s evolving hydrogen market and Europe’s largest potential renewable natural gas market. Germany has approximately 8,900 active biogas installations and approximately 280 of them are producing RNG today. These existing facilities are potential candidates for conversion to renewable natural gas and potentially decentralized green hydrogen production.

Exposure to the fast-growing medical oxygen market

Inmatec’s business operations have expanded significantly year-over-year from 2019 to 2020. This expansion is largely attributed to the associated demand from the COVID-19 pandemic response, which requires larger amounts of medical grade oxygen in hospitals around the world. This exposure is beneficial to Xebec by giving the company the capabilities to now manufacture and sell this equipment in North America and makes the company one of the few with these capabilities in Canada. Ultimately, the pandemic has helped hospitals realize the cost benefits and self-sufficiency that comes with onsite oxygen generation.

The Acquisition, which is one of the two “LOI Acquisitions” announced by Xebec on December 8, 2020, will be financed with the proceeds from the public offering and the concurrent private placement announced by Xebec on December 8, 2020 and December 9, 2020. The release of proceeds from such public offering and the concurrent private placement and the exchange of the subscription receipts into common shares of the Corporation are not conditional upon the closing of the Acquisition. The Acquisition is expected to close on or about February 28, 2021. The Acquisition has been unanimously approved by the Board of Directors of Xebec and is subject to regulatory approval and other customary closing conditions.

Advisors

Desjardins Capital Markets and TD Securities Inc. acted as financial advisors on the Acquisition.

Related links

https://www.xebecinc.com

https://www.inmatec.de/en/startsite.html

Investor Relations:

Xebec Adsorption Inc.
Brandon Chow, Investor Relations Manager
[email protected]
+1 450.979.8700 ext 5762

Media Inquiries:

Public Stratégies et Conseils for Xebec
Victor Henriquez, Senior Partner
[email protected]
+1 514.377.1102

About Inmatec

Inmatec is a leading manufacturer of nitrogen and oxygen generators. With innovative stationary and mobile plants, the company is setting new standards in the on-site production of nitrogen and oxygen. Inmatec’s N2 and O2 product lines with PSA or membrane-based technologies offer solutions to meet the needs of customers of all sizes. In addition, the company offers customer-specific solutions for a range of N2 and O2 applications as part of its special plant construction. For more information, www.inmatec.de.

About Xebec Adsorption Inc.

Xebec is a global provider of gas generation, purification and filtration solutions for the industrial, energy and renewables marketplace. Well-positioned in the energy transition space with proprietary technologies that transform raw gases into clean sources of renewable energy, Xebec’s 1,500+ customers range from small to multi-national corporations, governments and municipalities looking to reduce their carbon footprints. Headquartered in Montréal, Québec, Canada, Xebec has several Sales and Support offices in North America and Europe, as well as two manufacturing facilities in Montréal and Shanghai. Xebec trades on the TSX Venture Exchange under the symbol “XBC”. For more information, www.xebecinc.com.


Cautionary Statement


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release contains forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements, and subject to risks and uncertainties. Generally, forward-looking statements can be identified by the use of terminology such as “plans”, “seeks”, “expects”, “estimates”, “intends”, “anticipates”, “believes”, “could”, “might”, “likely” or variations of such words, or statements that certain actions, events or results “may”, “will”, “could”, “would”, “might”, “will be taken”, “occur”, “be achieved” or other similar expressions. Forward-looking statements also include, but are not limited to, the statements regarding Xebec’s and Inmatec’s business objectives, expected growth, results of operation, performance and financial results, statements with respect to the Acquisition, including the expected timing and completion, statements with respect to the anticipated benefits of the Acquisition and Xebec’s ability to successfully integrate the Acquisition and the expected financial performance and future revenues related thereto. Forward-looking statements, including statements concerning future capital expenditures, revenues, expenses, earnings, economic performance, indebtedness, financial condition, losses and future prospects as well as the expectations of management of Xebec with respect to information regarding the business and the expansion and growth of Xebec operations, involve risks, uncertainties and other factors that could cause actual results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements are subject to business and economic factors and uncertainties, and other factors that could cause actual results to differ materially from these forward-looking statements, including the relevant assumptions and risks factors set out in Xebec’s public documents, including in the most recent annual management discussion and analysis and annual information form, filed on SEDAR at www.sedar.com. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. These risks, uncertainties and other factors include, among others, the uncertain and unpredictable condition of global economy, notably as a consequence of the Covid-19 pandemic, Xebec’s capacity to generate revenue growth,
the availability to Xebec of financing and credit alternatives and access to capital,
Xebec’s capacity to meet all its other commitments and business plans, Xebec’s limited number of customers, the potential loss of key employees, , the possible failure to realize the anticipated benefits from the Acquisition, changes in the terms of the Acquisition, increased indebtedness, transitional risks, acquisition integration related risks, loss of certain key personnel from Inmatec, potential undisclosed costs or liabilities associated with the Acquisition, the information provided by Inmatec not being accurate or complete, changes in exchange rates, changes in general economic conditions, share price volatility, and other factors. Although Xebec believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, Xebec disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.



Ellington Residential Mortgage REIT Announces Dividend for the Fourth Quarter of 2020

Ellington Residential Mortgage REIT Announces Dividend for the Fourth Quarter of 2020

OLD GREENWICH, Conn.–(BUSINESS WIRE)–
Ellington Residential Mortgage REIT (NYSE: EARN) (the “Company”) today announced that its Board of Trustees has declared a dividend for the fourth quarter of 2020 of $0.28 per share, payable on January 25, 2021, to common shareholders of record as of December 31, 2020.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical in nature and can be identified by words such as “anticipate,” “estimate,” “will,” “should,” “may,” “expect,” “project,” “believe,” “intend,” “seek,” “plan” and similar expressions or their negative forms, or by references to strategy, plans, or intentions. For example, our results can fluctuate from month to month and quarter to quarter depending on a variety of factors, some of which are beyond our control and/or difficult to predict, including, without limitation, changes in interest rates, changes in default rates and prepayment speeds, and other changes in market and economic conditions, including changes resulting from the economic effects related to the COVID-19 pandemic, and associated responses to the pandemic. Our actual results may differ from our beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Furthermore, forward-looking statements are subject to risks and uncertainties, including, among other things, those described under Item 1A to the Company’s Annual Report on Form 10-K filed on March 12, 2020 and Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q filed on May 11, 2020, which can be accessed through the link to our SEC filings under “For Our Shareholders” on our website (www.earnreit.com) or at the SEC’s website (www.sec.gov). Other risks, uncertainties, and factors that could cause actual results to differ materially from those projected may be described from time to time in reports we file with the SEC, including reports on Forms 10-Q, 10-K and 8-K. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

About Ellington Residential Mortgage REIT

Ellington Residential Mortgage REIT is a mortgage real estate investment trust that specializes in acquiring, investing in and managing residential mortgage- and real estate-related assets, with a primary focus on residential mortgage-backed securities for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored enterprise. Ellington Residential Mortgage REIT is externally managed and advised by Ellington Residential Mortgage Management LLC, an affiliate of Ellington Management Group, L.L.C.

Investors:

Investor Relations

Ellington Residential Mortgage REIT

(203) 409-3773

[email protected]

or

Media:

Amanda Klein or Kevin FitzGerald

Gasthalter & Co.

for Ellington Residential Mortgage REIT

(212) 257-4170

[email protected]

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Construction & Property REIT

MEDIA:

SHAREHOLDER ALERT: Block & Leviton LLP Reminds Investors that it has Filed a Lawsuit Against Boston Scientific Corporation for Securities Fraud; Investors Who Lost Money Should Contact the Firm

BOSTON, Dec. 17, 2020 (GLOBE NEWSWIRE) — On November 17, 2020, Boston Scientific Corporation (NYSE: BSX) stunned the markets when it announced that it had “initiated a global, voluntary recall of the unused inventory of the LOTUS Edge Aortic Valve System due to complexities associated with the product.” The Company further stated that it “has chosen to retire the entire LOTUS product platform immediately,” and that it expected to record $225 to $300 million in pre-tax GAAP charges as a result of this decision. BSX shares fell approximately 8% on heavier than usual volume, representing billions of dollars in lost market capitalization.

Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on behalf of shareholders against Boston Scientific and certain of its executives for securities fraud. Investors who purchased BSX shares between April 24, 2019 and November 16, 2020 and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email at [email protected], or at https://www.blockleviton.com/cases/bsx. The lead plaintiff deadline is February 2, 2021.

The lawsuit was filed in the U.S. District Court for the District of Massachusetts, located at the John Joseph Moakley U.S. Courthouse, 1 Courthouse Way, Suite 2300, Boston, MA 02210. The case is captioned Errichiello v. Boston Scientific Corp., et al., No. 1:20-cv-12225 (D. Mass.), and has been assigned to the Honorable Douglas P. Woodlock. A related action has been filed in the Eastern District of New York, Jevons v. Boston Scientific Corp., et al., No. 1:20-cv-05894 (E.D.N.Y.).

If you purchased or acquired shares of Boston Scientific between April 24, 2019 and November 16, 2020 and have questions about your legal rights or possess information relevant to this matter, please contact Block & Leviton attorneys at (617) 398-5600, via email at [email protected], or at https://www.blockleviton.com/cases/bsx. The deadline to seek appointment as lead plaintiff in the matter is February 2, 2021.

Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the country’s financial markets. The firm represents many of the nation’s largest institutional investors as well as individual investors in securities litigation throughout the United States. The firm’s lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: [email protected]
SOURCE: Block & Leviton LLP
www.blockleviton.com



Seacoast Banking Corporation of Florida Announces Share Repurchase Program

STUART, Fla., Dec. 17, 2020 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF) announced that its Board of Directors (the “Board”) has adopted a share repurchase program. Under the repurchase program, which will expire on December 31, 2021, the Company may repurchase, from time to time, up to $100 million of its shares of common stock, representing approximately 6.1% of the Company’s outstanding common stock as of December 16, 2020.

The repurchase program permits shares to be repurchased in the open market, by block purchase, in privately negotiated transactions, in one or more transactions from time to time, or pursuant to any trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the “Exchange Act”). Open market purchases will be conducted in accordance with the limitations set forth in Rule 10b-18 of the Exchange Act and other applicable legal and regulatory requirements.

The timing and actual number of shares repurchased will be made at the Company’s discretion and will depend on a variety of factors including, without limitation, price, corporate and regulatory requirements, market conditions, Seacoast’s financial performance, and bank capital and liquidity requirements and priorities. The repurchase program does not obligate the Company to purchase any particular number of shares.

The repurchase program may be suspended, terminated or modified by the Board without notice at any time for any reason, including, without limitation, market conditions, the cost of repurchasing shares, the availability of alternative investment opportunities, capital and liquidity objectives, and other factors deemed appropriate by Seacoast’s management.

Commenting on the share repurchase program, Dennis S. Hudson, III, Seacoast’s Chairman and Chief Executive Officer said, “We are committed to maintaining a fortress balance sheet while also building long-term shareholder value, and we will continue to support our objective to maintain robust capital strength that ranks among the highest in our peer group. Given our confidence in our forward outlook, we felt it appropriate to add another capital management option for the coming year and as the overall economic recovery becomes clearer.”

About Seacoast Banking Corporation of Florida (NASDAQ: SBCF)

Seacoast Banking Corporation of Florida is one of the largest community banks headquartered in Florida with approximately $8.3 billion in assets and $6.9 billion in deposits as of September 30, 2020. The Company provides integrated financial services including commercial and retail banking, wealth management, and mortgage services to customers through advanced banking solutions, and 51 traditional branches of its locally-branded, wholly-owned subsidiary bank, Seacoast Bank. Offices stretch from Fort Lauderdale, Boca Raton and West Palm Beach north through the Daytona Beach area, into Orlando and Central Florida and the adjacent Tampa market, and west to Okeechobee and surrounding counties. More information about the Company is available at www.SeacoastBanking.com.



Cautionary Notice Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning, and protections, of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, without limitation, statements about future financial and operating results, cost savings, enhanced revenues, economic and seasonal conditions in our markets, and improvements to reported earnings that may be realized from cost controls, tax law changes, new initiatives and for integration of banks that we have acquired, as well as statements with respect to Seacoast’s objectives, strategic plans, including Vision 2020, expectations and intentions and other statements that are not historical facts, any of which may be impacted by the COVID-19 pandemic and related effects on the U.S. economy. Actual results may differ from those set forth in the forward-looking statements.

Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates and intentions about future performance and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance or achievements of Seacoast to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. You should not expect us to update any forward-looking statements.

All statements other than statements of historical fact could be forward-looking statements. You can identify these forward-looking statements through our use of words such as “may”, “will”, “anticipate”, “assume”, “should”, “support”, “indicate”, “would”, “believe”, “contemplate”, “expect”, “estimate”, “continue”, “further”, “plan”, “point to”, “project”, “could”, “intend”, “target” or other similar words and expressions of the future. These forward-looking statements may not be realized due to a variety of factors, including, without limitation: the effects of future economic and market conditions, including seasonality and the adverse impact of COVID-19 (economic and otherwise); governmental monetary and fiscal policies, including interest rate policies of the Board of Governors of the Federal Reserve, as well as legislative, tax and regulatory changes (including potential future legislation); changes in accounting policies, rules and practices, including the impact of the adoption of CECL; our participation in the PPP program; the risks of changes in interest rates on the level and composition of deposits, loan demand, liquidity and the values of loan collateral, securities, and
interest sensitive assets and liabilities; interest rate risks, sensitivities and the shape of the yield curve; uncertainty related to the impact of LIBOR calculations on securities and loans; changes in borrower credit risks and payment behaviors; changes in the availability and cost of credit and capital in the financial markets; changes in the prices, values and sales volumes of residential and commercial real estate; our ability to comply with any regulatory requirements; the effects of problems encountered by other financial institutions that adversely affect us or the banking industry; our concentration in commercial real estate loans; the failure of assumptions and estimates, as well as differences in, and changes to, economic, market and credit conditions; the impact on the valuation of our investments due to market volatility or counterparty payment risk; statutory and regulatory dividend restrictions; increases in regulatory capital requirements for banking organizations generally; the risks of mergers, acquisitions and divestitures, including our ability to continue to identify acquisition targets and successfully acquire desirable financial institutions; changes in technology or products that may be more difficult, costly, or less effective than anticipated; our ability to identify and address increased cybersecurity risks; inability of our risk management framework to manage risks associated with our business; dependence on key suppliers or vendors to obtain equipment or services for our business on acceptable terms; reduction in or the termination of our ability to use the mobile-based platform that is critical to our business growth strategy; the effects of war or other conflicts, acts of terrorism, natural disasters, health emergencies, epidemics or pandemics, or other catastrophic events that may affect general economic conditions; unexpected outcomes of and the costs associated with, existing or new litigation involving us; our ability to maintain adequate internal controls over financial reporting; potential claims, damages, penalties, fines and reputational damage resulting from pending or future litigation, regulatory proceedings and enforcement actions; the risks that our deferred tax assets could be reduced if estimates of future taxable income from our operations and tax planning strategies are less than currently estimated and sales of our capital stock could trigger a reduction in the amount of net operating loss carryforwards that we may be able to utilize for income tax purposes; the effects of competition from other commercial banks, thrifts, mortgage banking firms, consumer finance companies, credit unions, securities brokerage firms, insurance companies, money market and other mutual funds and other financial institutions operating in our market areas and elsewhere, including institutions operating regionally, nationally and internationally, together with such competitors offering banking products and services by mail, telephone, computer and the Internet; and the failure of assumptions underlying the establishment of reserves for possible loan losses.

Given the many unknowns and risks being heavily weighted to the downside, our forward-looking statements are subject to the risk that conditions will be substantially different than we are currently expecting. If efforts to contain COVID-19 are unsuccessful and restrictions on movement last into the fourth quarter and beyond, the recession would be much longer and much more severe. Ineffective fiscal stimulus, or an extended delay in implementing it, are also major downside risks. The deeper the recession is, and the longer it lasts, the more it will damage consumer fundamentals and sentiment. This could both prolong the recession, and/or make any recovery weaker. Similarly, the recession could damage business fundamentals. And an extended global recession due to COVID-19 would weaken the U.S. recovery. As a result, the outbreak and its consequences, including responsive measures to manage it, have had and are likely to continue to have an adverse effect, possibly materially, on our business and financial performance by adversely affecting, possibly materially, the demand and profitability of our products and services, the valuation of assets and our ability to meet the needs of our customers.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary notice, including, without limitation, those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2019, and our quarterly reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020 under “Special Cautionary Notice Regarding Forward-looking Statements” and “Risk Factors”, and otherwise in our SEC reports and filings. Such reports are available upon request from the Company, or from the Securities and Exchange Commission, including through the SEC’s Internet website at www.sec.gov.

Charles M. Shaffer
President and Chief Operating Officer
Seacoast Banking Corporation of Florida
(772) 221-7003



Calamos Investments Closed-End Funds’ (NASDAQ: CHI, CHY, CSQ, CGO, CHW, and CCD) Mandatory Redeemable Preferred Shares Announce Change in Rating Agency to Kroll Bond Rating Agency from Fitch Ratings

PR Newswire

NAPERVILLE, Ill., Dec. 17, 2020 /PRNewswire/ — Calamos Investments announced the Calamos Closed-End Funds board of trustees for each of CHI, CHY, CSQ, CGO, CHW and CCD (the “Trusts”) has elected to terminate, effective December 17, 2020, the designation of Fitch Ratings, Inc. (Fitch) as the rating agency for each series of the Trusts’ Mandatory Redeemable Preferred Shares (MRPS) and replaced Fitch with Kroll Bond Rating Agency LLC (KBRA), a nationally recognized statistical rating organization (NRSRO).  KBRA has assigned each series of the outstanding Calamos MRPS a rating of ‘AA-‘.1

Fitch recently adopted changes to their closed-end fund rating methodology. These changes, in Calamos Investments’ view, reflect Fitch’s negative market outlook which is substantially different from the views of the Trusts’ adviser. While Fitch stated that it expects their criteria changes to have a negative impact on 311 closed-end funds, they also noted that “any potential rating changes are solely the result of the criteria change and that the underlying fundamentals of the closed-end funds have not changed”.2

For more information regarding Calamos Investments’ closed-end fund offerings, please visit www.calamos.com.

1See Press Release, “KBRA Assigns Ratings to Mandatory Redeemable Preferred Shares of Six Calamos Closed-End Funds”

2 See Press Release, “Fitch Places 311 Closed-End Fund Ratings Under Criteria Observation”

Important Notes about Performance and Risk
Past performance is no guarantee of future results. As with other investments, market price will fluctuate with the market and upon sale, your shares may have a market price that is above or below net asset value and may be worth more or less than your original investment. Returns at NAV reflect the deduction of the Fund’s management fee, debt leverage costs and other expenses. You can purchase or sell common shares daily. Like any other stock, market price will fluctuate with the market. Upon sale, your shares may have a market price that is above or below net asset value and may be worth more or less than your original investment. Shares of closed-end funds frequently trade at a discount which is a market price that is below their net asset value.

About Calamos

Calamos Investments is a diversified global investment firm offering innovative investment strategies including alternatives, multi-asset, convertible, fixed income, and equity. The firm offers strategies through separately managed portfolios, mutual funds, closed-end funds, private funds, and UCITS funds. Clients include major corporations, pension funds, endowments, foundations and individuals, as well as the financial advisors and consultants who serve them. Headquartered in the Chicago metropolitan area, the firm also has offices in New York, San Francisco, Milwaukee and the Miami area. For more information, please visit www.calamos.com.

*Calamos Investments LLC, referred to herein as Calamos Investments®, is a financial services company offering such services through its subsidiaries: Calamos Advisors LLC, Calamos Wealth Management LLC, Calamos Investments LLP and Calamos Financial Services LLC. 

Cision View original content:http://www.prnewswire.com/news-releases/calamos-investments-closed-end-funds-nasdaq-chi-chy-csq-cgo-chw-and-ccd-mandatory-redeemable-preferred-shares-announce-change-in-rating-agency-to-kroll-bond-rating-agency-from-fitch-ratings-301195584.html

SOURCE Calamos Investments